Published in Ann Surg on February 01, 2010
Advances in the management of acute liver failure. World J Gastroenterol (2013) 0.91
Current developments in pediatric liver transplantation. World J Hepatol (2015) 0.81
A case report of a completely vanished liver graft after auxiliary partial orthotopic liver transplantation. Hippokratia (2016) 0.75
A new rat model of auxiliary partial heterotopic liver transplantation with liver dual arterial blood supply. Exp Ther Med (2014) 0.75
Current status of the organ replacement approach for malignancies and an overture for organ bioengineering and regenerative medicine. Organogenesis (2014) 0.75
A Comparison between splenic fossa and subhepatic fossa auxiliary partial heterotopic liver transplantation in a porcine model. Liver Transpl (2016) 0.75
Auxiliary partial liver transplantation for acute liver failure using "high risk" grafts: Case report. World J Gastroenterol (2016) 0.75
Regeneration and Cell Recruitment in an Improved Heterotopic Auxiliary Partial Liver Transplantation Model in the Rat. Transplantation (2017) 0.75
Postoperative imaging findings in children with auxiliary partial orthotopic liver transplant (APOLT). Pediatr Radiol (2016) 0.75
Pediatric liver failure: we came, we saw, but have we conquered? F1000Res (2017) 0.75
Acute liver failure. Lancet (2010) 3.39
Acute liver failure in children: the first 348 patients in the pediatric acute liver failure study group. J Pediatr (2006) 3.03
Guidelines for the diagnosis and treatment of cholangiocarcinoma: an update. Gut (2012) 2.91
Source and characterization of hepatic macrophages in acetaminophen-induced acute liver failure in humans. Hepatology (2012) 2.81
Hereditary fibrinogen A alpha-chain amyloidosis: phenotypic characterization of a systemic disease and the role of liver transplantation. Blood (2009) 2.30
Efficacy and safety of valganciclovir vs. oral ganciclovir for prevention of cytomegalovirus disease in solid organ transplant recipients. Am J Transplant (2004) 2.23
Survival of human immunodeficiency virus-infected liver transplant recipients. J Infect Dis (2003) 2.17
Aerobic capacity during cardiopulmonary exercise testing and survival with and without liver transplantation for patients with chronic liver disease. Liver Transpl (2013) 2.05
Evidence of differential risk for posttransplantation malignancy based on pretransplantation cause in patients undergoing liver transplantation. Liver Transpl (2002) 2.00
Safety and efficacy of N-acetylcysteine in children with non-acetaminophen-induced acute liver failure. Liver Transpl (2008) 1.97
Diagnosis of nonalcoholic fatty liver disease in children and adolescents: position paper of the ESPGHAN Hepatology Committee. J Pediatr Gastroenterol Nutr (2012) 1.91
Lessons from look-back in acute liver failure? A single centre experience of 3300 patients. J Hepatol (2013) 1.83
Intravenous N-acetylcysteine in pediatric patients with nonacetaminophen acute liver failure: a placebo-controlled clinical trial. Hepatology (2013) 1.78
A critical review of the health-related quality of life of children and adolescents after liver transplantation. Liver Transpl (2005) 1.75
Mucinous cystic neoplasms of the liver: a clinicopathological study and comparison with intraductal papillary neoplasms of the bile duct. Mod Pathol (2011) 1.74
One liver, three recipients: segment IV from split-liver procedures as a source of hepatocytes for cell transplantation. Transplantation (2004) 1.62
Mycophenolate mofetil as rescue treatment for autoimmune liver disease in children: a 5-year follow-up. J Hepatol (2009) 1.61
Neonatal hemochromatosis--medical treatment vs. transplantation: the king's experience. Liver Transpl (2005) 1.60
Monitoring mycophenolate in liver transplant recipients: toward a therapeutic range. Liver Transpl (2004) 1.58
A genetic study of Wilson's disease in the United Kingdom. Brain (2013) 1.53
Aetiology and management of extrahepatic portal vein obstruction in children: King's College Hospital experience. J Pediatr Gastroenterol Nutr (2008) 1.48
Distinct microRNA profiles are associated with the severity of hepatitis C virus recurrence and acute cellular rejection after liver transplantation. Liver Transpl (2013) 1.48
Primary pancreatic lymphoma: diagnostic and therapeutic dilemma. Pancreas (2006) 1.47
Alcohol dehydrogenase-specific T-cell responses are associated with alcohol consumption in patients with alcohol-related cirrhosis. Hepatology (2013) 1.47
Cystatin C, an easy and reliable marker for assessment of renal dysfunction in children with liver disease and after liver transplantation. Liver Transpl (2005) 1.47
Serum hepatocyte growth factor and vascular endothelial growth factor in children with acute liver failure. J Pediatr Gastroenterol Nutr (2007) 1.47
Pretransplant MELD score and post liver transplantation survival in the UK and Ireland. Liver Transpl (2004) 1.45
Liver transplantation in human immunodeficiency virus-infected patients: procoagulant, but is antithrombotic prophylaxis required? Liver Transpl (2012) 1.45
Living-donor liver transplantation with monosegments. Transplantation (2003) 1.45
Re-evaluation of the penicillamine challenge test in the diagnosis of Wilson's disease in children. J Hepatol (2007) 1.44
Chronic liver disease related to 6-thioguanine in children with acute lymphoblastic leukaemia. J Hepatol (2005) 1.44
Assessing nutritional status in children with chronic liver disease. J Gastroenterol Hepatol (2005) 1.43
Diaphragmatic dysfunction after pediatric orthotopic liver transplantation. Transplantation (2002) 1.43
Death of a living liver donor: opening Pandora's box. Liver Transpl (2013) 1.43
Live organ-donation for islet transplantation. Lancet (2005) 1.40
Comparison of a new fibrin sealant with standard topical hemostatic agents. Arch Surg (2004) 1.39
Is single-port laparoscopy feasible after liver transplant? Pediatr Transplant (2013) 1.37
Improving the techniques for human hepatocyte transplantation: report from a consensus meeting in London. Cell Transplant (2012) 1.31
Current status of hepatocyte transplantation. Transplantation (2012) 1.28
Spontaneous rupture of hepatocellular carcinoma: a Western experience. Am J Surg (2008) 1.25
Improved survival in a cohort of trial participants with metastatic castration-resistant prostate cancer demonstrates the need for updated prognostic nomograms. Eur Urol (2013) 1.24
Inflammatory pseudo-tumor of the liver: a rare pathological entity. World J Surg Oncol (2011) 1.19
Hepatocyte transplantation for inherited factor VII deficiency. Transplantation (2004) 1.18
Update on totally implantable venous access devices. Surg Oncol (2012) 1.17
Pharmacological interventions for nonalcoholic fatty liver disease in adults and in children: a systematic review. J Pediatr Gastroenterol Nutr (2009) 1.17
The role of mitochondria in ischemia/reperfusion injury. Transplantation (2002) 1.15
Overcoming the limitations of living donor and split liver transplantation: a proposal for adult recipients (the best of the East in the West). Liver Transpl (2008) 1.15
Anatomical variations of the common carotid artery bifurcation. ANZ J Surg (2006) 1.13
Liver Transplantation for Hereditary Transthyretin Amyloidosis: After 20 Years Still the Best Therapeutic Alternative? Transplantation (2015) 1.13
Serum levels of CK18 M30 and leptin are useful predictors of steatohepatitis and fibrosis in paediatric NAFLD. J Pediatr Gastroenterol Nutr (2010) 1.13
Management of neuroendocrine liver metastases. Am J Surg (2004) 1.13
Liver transplantation for Budd-Chiari syndrome. Transplantation (2002) 1.12
Metabolic assessment of human liver transplants from biopsy samples at the donor and recipient stages using high-resolution magic angle spinning 1H NMR spectroscopy. Anal Chem (2005) 1.11
How can we enhance undergraduate medical training in the operating room? A survey of student attitudes and opinions. J Surg Educ (2013) 1.11
Isolation of hepatocytes from livers from non-heart-beating donors for cell transplantation. Liver Transpl (2006) 1.10
Pseudoaneurysm following laparoscopic cholecystectomy. Hepatobiliary Pancreat Dis Int (2007) 1.10
Emergency liver transplantation following severe liver trauma. Liver Transpl (2008) 1.09
Intraportal transplantation of human bone marrow mesenchymal stem cells in pigs with fulminant hepatic failure. Hepatology (2013) 1.09
Absence of cytomegalovirus-resistance mutations after valganciclovir prophylaxis, in a prospective multicenter study of solid-organ transplant recipients. J Infect Dis (2004) 1.08
Ruptured hepatocellular carcinoma following chemoembolization: a western experience. Hepatobiliary Pancreat Dis Int (2007) 1.08
Secondary bile acids: an underrecognized cause of colon cancer. World J Surg Oncol (2014) 1.07
Selective embolization for bleeding visceral artery pseudoaneurysms in patients with pancreatitis. Hepatobiliary Pancreat Dis Int (2010) 1.07
How we treat sickle hepatopathy and liver transplantation in adults. Blood (2014) 1.07
The development of new density gradient media for purifying human islets and islet-quality assessments. Transplantation (2004) 1.07
Optimization of the cryopreservation and thawing protocol for human hepatocytes for use in cell transplantation. Liver Transpl (2010) 1.07
Leukocyte infiltration and inflammatory antigen expression in cadaveric and living-donor livers before transplant. Transplantation (2003) 1.06
Outcomes of liver transplantation in HIV-infected individuals: the impact of HCV and HBV infection. Liver Transpl (2004) 1.04
Mixed phenotype hepatocellular carcinoma after transarterial chemoembolization and liver transplantation. Liver Transpl (2011) 1.01
Graft positioning at liver transplantation in situs inversus. Liver Transpl (2006) 1.01
Human hepatocyte isolation and relationship of cell viability to early graft function. Cell Transplant (2003) 1.00
A dual role for hypoxia inducible factor-1α in the hepatitis C virus lifecycle and hepatoma migration. J Hepatol (2011) 1.00
Outcome after wait-listing for emergency liver transplantation in acute liver failure: a single centre experience. J Hepatol (2008) 1.00
The instant blood-mediated inflammatory reaction characterized in hepatocyte transplantation. Transplantation (2011) 0.99
Increased model for end-stage liver disease score at the time of liver transplant results in prolonged hospitalization and overall intensive care unit costs. Liver Transpl (2010) 0.98
Pharmacokinetic profile of ganciclovir after its oral administration and from its prodrug, valganciclovir, in solid organ transplant recipients. Clin Pharmacokinet (2005) 0.98
Primary undifferentiated embryonal sarcoma of the liver mistaken for hydatid disease. World J Surg Oncol (2010) 0.98
Meta-analysis of antecolic versus retrocolic gastric reconstruction after a pylorus-preserving pancreatoduodenectomy. HPB (Oxford) (2014) 0.98
Cancer trends in Lebanon: a review of incidence rates for the period of 2003-2008 and projections until 2018. Popul Health Metr (2014) 0.97
Unusually young age distribution of primary hepatic leiomyosarcoma: case series and review of the adult literature. World J Surg Oncol (2010) 0.97
Hydrodynamic gene delivery to the liver: theoretical and practical issues for clinical application. Curr Gene Ther (2009) 0.97
Guidance for clinical trials for children and adolescents with chronic hepatitis C. J Pediatr Gastroenterol Nutr (2011) 0.97